Side-by-side comparison of AI visibility scores, market position, and capabilities
Enterprise incentive compensation and sales performance platform with a proprietary multi-decade benchmark dataset. Covers Incent, Manage, Plan, and Forecast for global sales organizations.
Xactly is an enterprise sales performance management (SPM) software company founded in 2005 and headquartered in Denver, Colorado. The company offers a comprehensive suite covering incentive compensation management (Incent), territory and quota management (Manage), sales planning (Plan), and revenue forecasting (Forecast)—serving large sales organizations that need to automate complex commission calculations, manage compensation plans, and align sales territories with business goals.\n\nXactly's most distinctive asset is its proprietary benchmarking dataset built from decades of commission and performance data across thousands of companies, allowing customers to compare comp plans and rep performance against industry peers. This data moat provides Xactly with a defensible competitive position in the enterprise segment. The platform supports complex commission structures including multi-tier accelerators, splits, draws, recoveries, and channel partner compensation—calculations that are error-prone when managed in spreadsheets.\n\nXactly serves mid-market and enterprise customers across technology, financial services, manufacturing, and life sciences, with deep integrations into Salesforce, Workday, SAP, and Oracle HCM. The company was taken private by Vista Equity Partners in 2017 and has continued expanding its AI and predictive analytics capabilities for sales planning and quota attainment forecasting. Xactly competes with Varicent, CaptivateIQ, Anaplan, and SAP Commissions in the incentive compensation management market.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.